Rudolf Arnold

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

Anja Rinke, Hans‐Helge Müller, Carmen Schade‐Brittinger et al. · Journal of Clinical Oncology · 2009 · 2.5K citations

Medicine, Oncology, Pharmacotherapy +17

Glucagon-Like Peptide-1 and Glucose-Dependent Insulin-Releasing Polypeptide Plasma Levels in Response to Nutrients

Christine Herrmann, Rüdiger Göke, Gerd Richter et al. · Digestion · 2009 · 594 citations

Life Sciences, Endocrinology, Nutritional Sciences +12

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging

Anders Sundin, Rudolf Arnold, Éric Baudin et al. · Neuroendocrinology · 2017 · 497 citations · Full text

Medicine, Oncology, Radiology +14

ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas

Ulrich‐Frank Pape, Aurel Perren, Bruno Niederle et al. · Neuroendocrinology · 2012 · 462 citations · Full text

Medicine, Oncology, Surgery +17

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival

Anja Rinke, Michael Wittenberg, Carmen Schade‐Brittinger et al. · Neuroendocrinology · 2016 · 384 citations

Medicine, Oncology, Pharmacology +17